CLL Patient Voices Survey

SHARE VIA E-MAIL
DOWNLOAD
PRINT

Chronic Lymphocytic Leukemia Survey results

Top 3 drivers of treatment choice for patients

EN_AC_CLL-Patient-Survey-1

Long-term remission

EN_AC_CLL-Patient-Survey-2

Quality of life

EN_AC_CLL-Patient-Survey-3

Overall survival

Only 7% of patients indicate that duration of treatment is a driver of treatment choice

Influence of doctor and patient in treatment decisions

CLL patients felt that they and their doctor both had a HIGH LEVEL OF INFLUENCE

33% of CLL patients said they do nofully understand what their doctor tells them about their treatment

25% of CLL patients say their doctor does not involve them in treatment decisions

Overall treatment administration preferences

PATIENTS TOP REASONS FOR PREFERENCE

  • I wouldn't need to travel to the hospital so often
  • Tablets are less restrictive, I wouldn’t be attached to a drip
  • I’d only have to take a pill, there’d be no needles involved
  • It seems like a stronger treatment
  • I would only receive the treatment for a fixed period of time (I wouldn’t have to receive it forever)
  • It’s recommended by my doctor
  • It means I would have regular contact with my doctor/nurse
  • It seems like a stronger treatment
  • I would take my treatment at a fixed time
  • I would only receive the treatment for a fixed period of time (I wouldn’t have to receive it forever)
EN_AC_CLL-Patient-Survey-4

DISCUSS ALL TREATMENT OPTIONS WITH YOUR HEALTHCARE PROFESSIONAL

show more